4.5 Article

Valproic acid enhances Oct4 promoter activity through PI3K/Akt/mTOR pathway activated nuclear receptors

Journal

MOLECULAR AND CELLULAR ENDOCRINOLOGY
Volume 383, Issue 1-2, Pages 147-158

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.mce.2013.12.008

Keywords

Muscle; Oct4; Nuclear receptor; iPSC; VPA; Akt

Funding

  1. National Science Council of Taiwan, ROC [NSC-96-2311-B-008-006-MY3, NSC-99-2314-B-008-001-MY31]

Ask authors/readers for more resources

Valproic acid (VPA) has been shown to increase the reprogramming efficiency of induced pluripotent stem cells (iPSC) from somatic cells, but the mechanism by which VPA enhances iPSG induction has not been defined. Here we demonstrated that VPA directly activated Oct4 promoter activity through activation of the PI3 K/Akt/mTOR signaling pathway that targeted the proximal hormone response element (HRE, 41 22) in this promoter. The activating effect of VPA is highly specific as similar compounds or constitutional isomers failed to instigate Oct4 promoter activity. We further demonstrated that the upstream 2 half-sites in this HRE were essential to the activating effect of VPA and they were targeted by a subset of nuclear receptors, such as COUP-TFII and TR2. These findings show the first time that NRs are implicated in the VPA stimulated expression of stem cell-specific factors and should invite more investigation on the cooperation between VPA and NRs on iPSC induction. (C) 2013 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available